Page 122 - Vitamin D and Cancer

5 Vitamin D and Angiogenesis 109

23. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG (1991) Isolation of a human
placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl
Acad Sci USA 88:9267–9271
24. Schreiber AB, Winkler ME, Derynck R (1986) Transforming growth factor-alpha: a more
potent angiogenic mediator than epidermal growth factor. Science 232:1250–1253
25. Pepper MS, Belin D, Montesano R, Orci L, Vassalli JD (1990) Transforming growth factor-
beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic proper-
ties of endothelial cells in vitro. J Cell Biol 111:743–755
26. Adams RH, Alitalo K (2007) Molecular regulation of angiogenesis and lymphangiogenesis.
Nat Rev Mol Cell Biol 8:464–478
27. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N (1987)
Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature
329:630–632
28. Strieter RM, Kunkel SL, Elner VM, Martonyi CL, Koch AE, Polverini PJ, Elner SG (1992)
Interleukin-8. A corneal factor that induces neovascularization. Am J Pathol 141:1279–1284
29. Thompson TC, Southgate J, Kitchener G, Land H (1989) Multistage carcinogenesis induced
by ras and myc oncogenes in a reconstituted organ. Cell 56:917–930
30. Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF, Vallee BL (1985)
Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma
cells. Biochemistry 24:5480–5486
31. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J,
Radziejewski C, Maisonpierre PC, Yancopoulos GD (1996) Isolation of angiopoietin-1, a
ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87:1161–1169
32. Ziche M, Jones J, Gullino PM (1982) Role of prostaglandin E1 and copper in angiogenesis.
J Natl Cancer Inst 69:475–482
33. Harada S, Nagy JA, Sullivan KA, Thomas KA, Endo N, Rodan GA, Rodan SB (1994)
Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in
osteoblasts. J Clin Invest 93:2490–2496
34. Brouty-Boye D, Zetter BR (1980) Inhibition of cell motility by interferon. Science
208:516–518
35. Dvorak HF, Gresser I (1989) Microvascular injury in pathogenesis of interferon-induced
necrosis of subcutaneous tumors in mice. J Natl Cancer Inst 81:497–502
36. Sidky YA, Borden EC (1987) Inhibition of angiogenesis by interferons: effects on tumor-
and lymphocyte-induced vascular responses. Cancer Res 47:5155–5161
37. ÓReilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen
BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor
growth. Cell 88:277–285
38. Colorado PC, Torre A, Kamphaus G, Maeshima Y, Hopfer H, Takahashi K, Volk R,
Zamborsky ED, Herman S, Sarkar PK, Ericksen MB, Dhanabal M, Simons M, Post M, Kufe
DW, Weichselbaum RR, Sukhatme VP, Kalluri R (2000) Anti-angiogenic cues from vascular
basement membrane collagen. Cancer Res 60:2520–2526
39. Kamphaus GD, Colorado PC, Panka DJ, Hopfer H, Ramchandran R, Torre A, Maeshima Y,
Mier JW, Sukhatme VP, Kalluri R (2000) Canstatin, a novel matrix-derived inhibitor of
angiogenesis and tumor growth. J Biol Chem 275:1209–1215
40. Mongiat M, Sweeney SM, San Antonio JD, Fu J, Iozzo RV (2003) Endorepellin, a novel inhibi-
tor of angiogenesis derived from the C terminus of perlecan. J Biol Chem 278:4238–4249
41. Kalluri R (2002) Discovery of type IV collagen non-collagenous domains as novel integrin
ligands and endogenous inhibitors of angiogenesis. Cold Spring Harb Symp Quant Biol
67:255–266
42. Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, Bouck NP
(1990) A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and
functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA
87:6624–6628